发明授权
- 专利标题: Wireless optofluidic systems for programmable in vivo pharmacology and optogenetics
-
申请号: US15738043申请日: 2016-07-01
-
公开(公告)号: US11160489B2公开(公告)日: 2021-11-02
- 发明人: John A. Rogers , Michael Raymond Bruchas , Jaewoong Jeong , Jordan Gary McCall
- 申请人: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS , WASHINGTON UNIVERSITY IN ST. LOUIS
- 申请人地址: US IL Urbana; US MO St. Louis
- 专利权人: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS,WASHINGTON UNIVERSITY IN ST. LOUIS
- 当前专利权人: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS,WASHINGTON UNIVERSITY IN ST. LOUIS
- 当前专利权人地址: US IL Urbana; US MO St. Louis
- 代理机构: Leydig, Voit & Mayer, Ltd.
- 国际申请: PCT/US2016/040814 WO 20160701
- 国际公布: WO2017/004576 WO 20170105
- 主分类号: A61B5/00
- IPC分类号: A61B5/00 ; A61M5/142 ; A61B5/145 ; A61B5/01 ; A61B5/24 ; A61B5/291
摘要:
Provided are implantable, injectable and/or surface mounted biomedical devices and related methods for interfacing with a target tissue. The devices have a substrate, one or more microfluidic channels embedded in or supported by the substrate and a fluid actuator in operational communication with one or more reservoirs and responsive to a wireless control signal. The components of the device are specially configured and packaged to be ultra-thin and mechanically compliant. In some embodiments, the devices are self-powered and fully implantable. The devices can be shaped to provide injection in a minimally invasive manner, thereby avoiding unnecessary tissue damage and providing a platform for long-term implantation for interfacing with biological tissue.
公开/授权文献
信息查询